NEW YORK, July 24 (
Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.
Advertisement
Ethnicity and CV disease
NEW YORK, July 24 (Praxis Press) Rates of clinical cardiovascular (CV)disease differ among ethnic groups in Canada. Anand and colleagues studied the source of this variation in South Asian, Chinese and European Canadians. South Asian Canadians had the highest prevalence of clinical CV disease and a greater prevalence of key risk factors. However, European Canadians had the greatest degree of carotid intimal-medial thickening. Risk factors only partly explain ethnic differences in the rates of cl
July 25, 2000
Related Articles
Top brass at the US science agency aired monetary grievances before a Senate committee last week.
Drosophila pumps blood through its body with a long, tube-shaped muscle.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
